RE: Open day12 Oct 2022 08:41
Davand a rhetorical question one assumes!
The component parts that make up the present BOD do not align with the Company as it exists.
Firstly, it’s bloated numerical size is disproportionate to both the mkt cap and the employee numbers they are meant to ‘direct’ over. This might also have impacted in failing to benefit from ‘first-user advantage’ opportunities, most clearly manifested in the glacial company response to covid opportunities.
The BOD is skewed heavily to scientists. These are rarely of a business acumen, most notably witnessed when our cherished Dr Little ran the show leading to the near-suicidal march into expensive litigation. He is still present, presumably enjoying the sinecure he is endowed with.
As for our man in Taiwan, he may own plenty of shares, but anyone who has a clue as to his company contribution, answers on a postcard. The last time I looked he was responsible for PowerPoint presentations in Asia.
Our recently departed chairman AR perhaps most embodied the company ethos. A snappy dresser and old-fashioned City spiv caricature he may have been with a penchant for spraying out share options, but I struggle to find evidence of strong leadership and direction over the years.
Should the company one day cease to exist independently, then my guess would be the entire BOD would be removed. Any scientists worth their weight would then simply be retained on a common or garden salary rather than the cosy directorships they continue to enjoy.